Question · asked by 0 reviews
Fondaparinux vs heparin: Quality of life ‐ not reported
- Population
- patients with the initial treatment of venous thromboembolism in patients with cancer
- Intervention
- Fondaparinux
- Comparison
- heparin
- Outcome
- Quality of life ‐ not reported
The review found no eligible studies for this question.
What each review found
Current versions onlyNo studies found 4 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Fondaparinux vs heparin Quality of life ‐ not reported · patients with cancer with the initial treatment of VTE The review found no eligible studies for this question. Anticoagulation for the initial treatment of venous thromboembolism in people with cancer (2014) · Cochrane Headline outcomes onlyearlier version CD006649.PUB6, superseded | no estimate extracted | Not reported | No studies found |
Fondaparinux vs heparin Quality of life ‐ not reported · patients with the initial treatment of venous thromboembolism in patients with cancer The review found no eligible studies for this question. Anticoagulation for the initial treatment of venous thromboembolism in people with cancer (2011) · Cochrane Headline outcomes onlyearlier version CD006649.PUB3, superseded | no estimate extracted | Not reported | No studies found |
Fondaparinux vs heparin Quality of life ‐ not reported · patients with the initial treatment of venous thromboembolism in patients with cancer The review found no eligible studies for this question. Anticoagulation for the initial treatment of venous thromboembolism in people with cancer (2011) · Cochrane Headline outcomes onlyearlier version CD006649.PUB4, superseded | no estimate extracted | Not reported | No studies found |
Fondaparinux vs heparin Quality of life ‐ not reported · patients with the initial treatment of venous thromboembolism in patients with cancer The review found no eligible studies for this question. Anticoagulation for the initial treatment of venous thromboembolism in people with cancer (2011) · Cochrane Headline outcomes onlyearlier version CD006649.PUB5, superseded | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Anticoagulation for the initial treatment of venous thromboembolism in people with cancer 2021 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Fondaparinux vs heparin · patients with cancer with venous thromboembolism · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.